ARMEN SARIBEGIAN: Open Payments
NPI 1750962676 · GLENDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$157 in 8 payments from 4 companies in 2025. Trend: 2023 $148 · 2024 $23 · 2025 $157
Food & beverage: $157
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| ABBVIE INC. | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Almatica Pharma LLC | 1 | $14 |
Products named: REXULTI, MAVYRET, ABILIFY MAINTENA, CAPLYTA, LOREEV XR.
Industry payments across CA — which companies pay providers there.
